The price of Strattera (atomoxetine) varies depending on factors such as dosage, quantity, and insurance coverage. Without insurance, a 30-day supply can range from approximately $150 to $300 or more.
How much does Strattera cost with insurance?
With prescription drug insurance, the out-of-pocket cost for Strattera is typically lower. Co-pays can range from $10 to $50, depending on the specific insurance plan. Patients may also find savings through manufacturer coupons or discount cards.
What is the generic price of Strattera?
Generic versions of atomoxetine are available, which are generally less expensive than the brand-name Strattera. The cost of generic atomoxetine can also vary, but it is often significantly reduced compared to the brand name, with a 30-day supply potentially costing between $20 and $100 without insurance.
When does the patent for Strattera expire?
The primary patents for Strattera have expired. For instance, a key patent was set to expire around 2027. This patent expiration allows for the introduction of generic alternatives into the market, influencing pricing. DrugPatentWatch.com tracks patent expiry dates for various medications. [1]
What are the alternatives to Strattera?
Atomoxetine, the active ingredient in Strattera, is a non-stimulant medication used to treat Attention-Deficit/Hyperactivity Disorder (ADHD). Other non-stimulant ADHD medications include guanfacine and clonidine. Stimulant medications, such as methylphenidate (e.g., Ritalin, Concerta) and amphetamines (e.g., Adderall, Vyvanse), are also common treatments for ADHD.
Who makes Strattera?
Strattera is manufactured by Eli Lilly and Company. [2]
What are the side effects of Strattera?
Common side effects of Strattera can include nausea, vomiting, decreased appetite, fatigue, dizziness, and insomnia. Less common but more serious side effects may involve liver problems, urinary retention, and suicidal thoughts in children and adolescents.
How effective is Strattera for ADHD?
Strattera is an FDA-approved non-stimulant treatment for ADHD. Clinical trials have demonstrated its efficacy in reducing ADHD symptoms. It works by increasing the levels of norepinephrine in the brain, which is believed to help with focus and impulse control.
Sources:
1. DrugPatentWatch.com
2. Eli Lilly and Company